Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The case for indicator condition-guided HIV screening

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lazarus, JV, Hoekstra, M, Raben, D, Delpech, V, Coenen, T, Lundgren, JD & HIV in Europe Initiative Steering Committee 2013, 'The case for indicator condition-guided HIV screening' HIV Medicine, vol. 14, no. 7, pp. 445-8. https://doi.org/10.1111/hiv.12022

APA

Lazarus, J. V., Hoekstra, M., Raben, D., Delpech, V., Coenen, T., Lundgren, J. D., & HIV in Europe Initiative Steering Committee (2013). The case for indicator condition-guided HIV screening. HIV Medicine, 14(7), 445-8. https://doi.org/10.1111/hiv.12022

CBE

Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD, HIV in Europe Initiative Steering Committee. 2013. The case for indicator condition-guided HIV screening. HIV Medicine. 14(7):445-8. https://doi.org/10.1111/hiv.12022

MLA

Vancouver

Author

Lazarus, J V ; Hoekstra, M ; Raben, D ; Delpech, V ; Coenen, T ; Lundgren, J D ; HIV in Europe Initiative Steering Committee. / The case for indicator condition-guided HIV screening. In: HIV Medicine. 2013 ; Vol. 14, No. 7. pp. 445-8.

Bibtex

@article{c8f229929a1c4d91b4890c157e7d1381,
title = "The case for indicator condition-guided HIV screening",
abstract = "One-half of the estimated 2.5 million people who now live with HIV in the World Health Organization (WHO) European Region are still diagnosed late. A central question is which clinical scenarios should trigger an HIV test recommendation in order to avoid late presentation. Drawing on the work of the HIV Indicator Diseases across Europe Study (HIDES), new guidance brings together in one place a list of the conditions that should result in an HIV screening recommendation.",
keywords = "Early Diagnosis, Europe, HIV, HIV Infections, Health Status Indicators, Homosexuality, Male, Humans, Male, Patient Acceptance of Health Care, Prenatal Diagnosis, Prevalence, World Health Organization",
author = "Lazarus, {J V} and M Hoekstra and D Raben and V Delpech and T Coenen and Lundgren, {J D} and {HIV in Europe Initiative Steering Committee}",
note = "{\circledC} 2013 British HIV Association.",
year = "2013",
month = "8",
doi = "10.1111/hiv.12022",
language = "English",
volume = "14",
pages = "445--8",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - The case for indicator condition-guided HIV screening

AU - Lazarus, J V

AU - Hoekstra, M

AU - Raben, D

AU - Delpech, V

AU - Coenen, T

AU - Lundgren, J D

AU - HIV in Europe Initiative Steering Committee

N1 - © 2013 British HIV Association.

PY - 2013/8

Y1 - 2013/8

N2 - One-half of the estimated 2.5 million people who now live with HIV in the World Health Organization (WHO) European Region are still diagnosed late. A central question is which clinical scenarios should trigger an HIV test recommendation in order to avoid late presentation. Drawing on the work of the HIV Indicator Diseases across Europe Study (HIDES), new guidance brings together in one place a list of the conditions that should result in an HIV screening recommendation.

AB - One-half of the estimated 2.5 million people who now live with HIV in the World Health Organization (WHO) European Region are still diagnosed late. A central question is which clinical scenarios should trigger an HIV test recommendation in order to avoid late presentation. Drawing on the work of the HIV Indicator Diseases across Europe Study (HIDES), new guidance brings together in one place a list of the conditions that should result in an HIV screening recommendation.

KW - Early Diagnosis

KW - Europe

KW - HIV

KW - HIV Infections

KW - Health Status Indicators

KW - Homosexuality, Male

KW - Humans

KW - Male

KW - Patient Acceptance of Health Care

KW - Prenatal Diagnosis

KW - Prevalence

KW - World Health Organization

U2 - 10.1111/hiv.12022

DO - 10.1111/hiv.12022

M3 - Journal article

VL - 14

SP - 445

EP - 448

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 7

ER -

ID: 43003151